Archive
Aesthetic Trends 2020: An overview
With an increased demand for beauty innovations coupled with growing wellness concerns, the medical aesthetic market is expected to embrace newer trends and techniques in
Revision treatments on the rise, says RealSelf report
RealSelf has revealed the fastest-growing cosmetic treatments of 2019 and industry predictions for 2020 in its new 2019 Aesthetics Trend Report. The 2019 Aesthetics Trend
Gender neutrality might be the next big thing
Dr Alexander Rivkin from the US talks about the changing perception of gender and the concept of gender fluidity. A Los Angeles-based cosmetic surgeon who
Facial fat transfer demand to soar, says report
Fat grafting for facial lifts to witness 10%+ increase by 2026. The global facial fat transfer market size is anticipated to reach USD 4.2 billion
How to make the most of Instagram for your business
Marketing your clinic on Instagram can prove to be a game-changer for your business. Our social media expert Ami Savla Hemani discusses key aspects of
Dr Richa’s Unique Clinic awarded
Dr Richa’s Unique Clinic, Nagpur, wins coveted award. Dr. Richa’s Unique Clinic in Nagpur won the Best Cosmetologist and Trichologist Clinic in Maharashtra at the
Skin problems on the rise in the capital
Rising pollution in Delhi-NCR takes its toll on the skin, too. As per a report in Businessinsider.in, toxic high pollution levels in Delhi-NCR is not
Mary Kay Inc. caps off landmark scientific credentialing year
73rd Society of cosmetic chemist meeting sponsored by Mary Kay Inc. to explore the application of skin with experts In 2019, Mary Kay Inc. continued
Galderma receives an optimistic upshot by European union for AKLIEF®
Galderma announced that AKLIEF® has completed the European decentralised procedure which will result in approval by all involved European member states Galderma announced that AKLIEF®
Janssen completes acquisition of investigational Bermekimab
The Janssen Pharmaceutical Companies announced the acquisition of all rights to Bermekimab, along with certain employees, from XBiotech Inc., for $750 million. The Janssen Pharmaceutical
